|
1
|
Gill AJ: Succinate dehydrogenase
(SDH)-deficient neoplasia. Histopathology. 72:106–116. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gill AJ, Hes O, Papathomas T, Šedivcová M,
Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, et
al: Succinate dehydrogenase (SDH)-deficient renal carcinoma: A
morphologically distinct entity: A clinicopathologic series of 36
tumors from 27 patients. Am J Surg Pathol. 38:1588–1602. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vanharanta S, Buchta M, McWhinney SR,
Virta SK, Peçzkowska M, Morrison CD, Lehtonen R, Januszewicz A,
Järvinen H, Juhola M, et al: Early-onset renal cell carcinoma as a
novel extraparaganglial component of SDHB-associated heritable
paraganglioma. Am J Hum Genet. 74:153–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-Part A: Renal, Penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gill AJ: Succinate dehydrogenase (SDH) and
mitochondrial driven neoplasia. Pathology. 44:285–292. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barletta JA and Hornick JL: Succinate
dehydrogenase-deficient tumors: Diagnostic advances and clinical
implications. Adv Anat Pathol. 19:193–203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rizza S, Montagna C, Cardaci S, Maiani E,
Di Giacomo G, Sanchez-Quiles V, Blagoev B, Rasola A, De Zio D,
Stamler JS, et al: S-nitrosylation of the mitochondrial chaperone
TRAP1 sensitizes hepatocellular carcinoma cells to inhibitors of
succinate dehydrogenase. Cancer Res. 76:4170–4182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eng C, Kiuru M, Fernandez MJ and Aaltonen
LA: A role for mitochondrial enzymes in inherited neoplasia and
beyond. Nat Rev Cancer. 3:193–202. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gottlieb E and Tomlinson IP: Mitochondrial
tumour suppressors: A genetic and biochemical update. Nat Rev
Cancer. 5:857–866. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Williamson SR, Eble JN, Amin MB, Gupta NS,
Smith SC, Sholl LM, Montironi R, Hirsch MS and Hornick JL:
Succinate dehydrogenase-deficient renal cell carcinoma: Detailed
characterization of 11 tumors defining a unique subtype of renal
cell carcinoma. Mod Pathol. 28:80–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuroda N, Yorita K, Nagasaki M, Harada Y,
Ohe C, Jeruc J, Raspollini MR, Michal M, Hes O and Amin MB: Review
of succinate dehydrogenase-deficient renal cell carcinoma with
focus on clinical and pathobiological aspects. Pol J Pathol.
67:3–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai TH and Lee WY: Succinate
dehydrogenase-deficient renal cell carcinoma. Arch Pathol Lab Med.
143:643–647. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eijkelenkamp K, Osinga TE, Links TP and
van der Horst-Schrivers ANA: Clinical implications of the
oncometabolite succinate in SDHx-mutation carriers. Clin Genet.
97:39–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang G and Rao P: Succinate
dehydrogenase-deficient renal cell carcinoma: A short review. Arch
Pathol Lab Med. 142:1284–1288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Agha RA, Franchi T, Sohrabi C, Mathew G
and Kerwan A; SCARE Group, : The SCARE 2020 guideline: Updating
consensus surgical CAse REport (SCARE) guidelines. Int J Surg.
84:226–230. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamai T, Higashi S, Murakami S, Arai K,
Namatame T, Kijima T, Abe H, Jamiyan T, Ishida K, Shirataki H and
Yoshida KI: Single nucleotide variants of succinate dehydrogenase A
gene in renal cell carcinoma. Cancer Sci. 112:3375–3387. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ooi A: Advances in hereditary
leiomyomatosis and renal cell carcinoma (HLRCC) research. Semin
Cancer Biol. 61:158–166. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Merino MJ, Torres-Cabala C, Pinto P and
Linehan WM: The morphologic spectrum of kidney tumors in hereditary
leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg
Pathol. 31:1578–1585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YB, Brannon AR, Toubaji A, Dudas ME,
Won HH, Al-Ahmadie HA, Fine SW, Gopalan A, Frizzell N, Voss MH, et
al: Hereditary leiomyomatosis and renal cell carcinoma
syndrome-associated renal cancer: Recognition of the syndrome by
pathologic features and the utility of detecting aberrant
succination by immunohistochemistry. Am J Surg Pathol. 38:627–637.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McEvoy CR, Koe L, Choong DY, Leong HS, Xu
H, Karikios D, Plew JD, Prall OW, Fellowes AP and Fox SB:
SDH-deficient renal cell carcinoma associated with biallelic
mutation in succinate dehydrogenase A: Comprehensive genetic
profiling and its relation to therapy response. NPJ Precis Oncol.
2:92018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yakirevich E, Ali SM, Mega A, McMahon C,
Brodsky AS, Ross JS, Allen J, Elvin JA, Safran H and Resnick MB: A
novel SDHA-deficient renal cell carcinoma revealed by comprehensive
genomic profiling. Am J Surg Pathol. 39:858–863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andrews KA, Ascher DB, Pires DEV, Barnes
DR, Vialard L, Casey RT, Bradshaw N, Adlard J, Aylwin S, Brennan P,
et al: Tumour risks and genotype-phenotype correlations associated
with germline variants in succinate dehydrogenase subunit genes
SDHB, SDHC and SDHD. J Med Genet. 55:384–394. 2018. View Article : Google Scholar : PubMed/NCBI
|
